Question 1

What specific benefits do you think this trial could offer me compared to standard treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer clinical trial (NCT05313815). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the radiation treatment be administered, and what should I expect during the sessions?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer clinical trial (NCT05313815). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer clinical trial (NCT05313815). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my overall health and cancer status be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer clinical trial (NCT05313815). Contact the study team or your healthcare provider for specific answers.

Question 5

Is there any additional therapy, like hormone therapy, that I might need during this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer clinical trial (NCT05313815). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or complications during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer clinical trial (NCT05313815). Contact the study team or your healthcare provider for specific answers.

What this study is about